What does Vaccinex, Inc. do?

Jun 22 2025 06:16 PM IST
share
Share Via
Vaccinex, Inc. is a clinical-stage biotechnology company focused on developing targeted biotherapeutics for serious diseases. As of December 2024, it reported net sales of $0 million and a net loss of $3 million, with a market cap of $1.90 million.
Overview:
Vaccinex, Inc. is a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics, focused on serious diseases within the Pharmaceuticals & Biotechnology industry. Financial Snapshot: Most recent Net Sales: 0 Million (Quarterly Results - Dec 2024) Most recent Net Profit: -3 Million (Quarterly Results - Dec 2024) Market-cap: USD 1.90 Million (Micro Cap) Key Metrics: P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: 0.43 Return on Equity: 797.03% Price to Book: -0.77 Contact Details: Address: 1895 Mount Hope Ave, ROCHESTER NY: 14620-4540 Tel: 1 585 2712700 Fax: 1 585 2712765 Website: http://www.vaccinex.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Vaccinex, Inc. technically bullish or bearish?
Sep 20 2025 07:20 PM IST
share
Share Via
Is Vaccinex, Inc. overvalued or undervalued?
Jun 25 2025 08:30 AM IST
share
Share Via
Is Vaccinex, Inc. technically bullish or bearish?
Jun 25 2025 08:27 AM IST
share
Share Via
How big is Vaccinex, Inc.?
Jun 22 2025 05:43 PM IST
share
Share Via